Mayank Verma

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMedical biochemistry - proteins and peptides (incl. medical proteomics)Microelectromechanical systems (MEMS)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 04, 2026
CD90 delineates distinct muscle stem cell states of quiescence and activation.

|Oct 27, 2025
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease.

Lorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker

|Jan 13, 2025
Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative disease.

Silvia Nitschke, Alina P Montalbano, Megan E Whiting

|Jun 06, 2024
Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell.

Mayank Verma, Yoko Asakura, Xuerui Wang

|Dec 27, 2019
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.

Mayank Verma, Yuko Shimizu-Motohashi, Yoko Asakura

|Jan 31, 2019
Inhibition of microRNA-92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy-related phenotype in mdx mice.

Mayank Verma, Yoko Asakura, Atsushi Asakura

Pageof 1

Frequent Collaborators

3 joint publications

Atsushi Asakura

2 joint publications

Yoko Asakura

2 joint publications

Felix Nitschke

2 joint publications

Berge A Minassian